SENESCORE Trademark

Trademark Overview


On Tuesday, July 9, 2024, a trademark application was filed for SENESCORE with the United States Patent and Trademark Office. The USPTO has given the SENESCORE trademark a serial number of 98638764. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, March 8, 2025. This trademark is owned by Ponce Therapeutics, Inc.. The SENESCORE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Biologic age scoring; Statistical scoring to determine a biologic age score of a patient; Anti-aging therapy; Anti-aging services; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy service...
senescore

General Information


Serial Number98638764
Word MarkSENESCORE
Filing DateTuesday, July 9, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, March 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSENES CORE
Goods and ServicesBiologic age scoring; Statistical scoring to determine a biologic age score of a patient; Anti-aging therapy; Anti-aging services; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells; Non-invasive testing; Non-invasive testing related to biologic age; Non-invasive testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePonce Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Tuesday, July 9, 2024NEW APPLICATION ENTERED
Friday, January 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 1, 2025ASSIGNED TO EXAMINER
Saturday, March 8, 2025NON-FINAL ACTION WRITTEN
Saturday, March 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 8, 2025NON-FINAL ACTION E-MAILED